VEGF 165 (AA 27-191) (Active) Protein
Kurzübersicht für VEGF 165 (AA 27-191) (Active) Protein (ABIN2018445)
Target
Protein-Typ
Biologische Aktivität
Spezies
Quelle
Reinheit
-
-
Proteineigenschaft
- AA 27-191
-
Produktmerkmale
- ED50 <16 ng/mL, measured in a cell proliferation assay using HUVEC cells.
-
Endotoxin-Niveau
- < 0.2 EU/μg, determined by LAL method.
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstituted in ddH2O or PBS at 100 μg/mL.
-
Buffer
- Lyophilized after extensive dialysis against PBS.
-
Lagerung
- -80 °C
-
Informationen zur Lagerung
- Lyophilized recombinant Human Vascular Endothelial Growth Factor 165 (VEGF-165) remains stable up to 6 months at -80°C from date of receipt. Upon reconstitution, Human Vascular Endothelial Growth Factor 165 (VEGF-165) should be stable up to 1 week at 4°C or up to 2 months at -20°C.
-
Haltbarkeit
- 6 months
-
-
- VEGF 165
-
Andere Bezeichnung
- Vascular Endothelial Growth Factor 165 (VEGF165)
-
Hintergrund
-
Vascular Endothelial Growth Factor is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascularized tissues, VEGF plays a prominent role in normal and pathological angiogenesis. Substantial evidence implicates VEGF in the induction of tumor metastasis and intra-ocular neovascular syndromes. VEGF signals through the three receptors, fms-like tyrosine kinase (flt-1), KDR gene product (the mouse homolog of KDR is the flk-1 gene product) and the flt4 gene product.
Synonyms: Vascular Endothelial Growth Factor, VPF, Folliculostellate cell-derived growth factor, Glioma-derived endothelial cell mitogen -
Molekulargewicht
- 20-26 kDa, observed by reducing SDS-PAGE.
-
NCBI Accession
- NP_001165097
Target
-